2nd Quarter - Report — BRAEBURN INC. FORMERLY KNOWN AS BRAEBUR… for BRAEBURN INC FORMERLY KNOWN AS BRAEBURN… (2020)

Firm

BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC

Client

BRAEBURN INC FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC

Income

—

Expenses

$100,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HR 4712, S3271 Fairness in Orphan Drug Exclusivity Act: General lobbying pertaining to opioid crisis; controlled substances and specialty pharmacies

Lobbyist	Covered position, as disclosed
EDWARD BUCKLEY	—

Contacted: Office of Natl Drug Control Policy (NDCP); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4712 (116th)

Medicare/Medicaid MMM

HR 4712, S3271 Fairness in Orphan Drug Exclusivity Act: General lobbying pertaining to opioid crisis; controlled substances and specialty pharmacies

Lobbyist	Covered position, as disclosed
EDWARD BUCKLEY	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Office of Natl Drug Control Policy (NDCP)

Bills named: H.R. 4712 (116th)

Insurance INS

HR 4712, S3271 Fairness in Orphan Drug Exclusivity Act: General lobbying pertaining to opioid crisis; controlled substances and specialty pharmacies

Lobbyist	Covered position, as disclosed
EDWARD BUCKLEY	—

Contacted: SENATE; Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES

Bills named: H.R. 4712 (116th)

Pharmacy PHA

HR 4712, S3271 Fairness in Orphan Drug Exclusivity Act: General lobbying pertaining to opioid crisis; controlled substances and specialty pharmacies

Lobbyist	Covered position, as disclosed
EDWARD BUCKLEY	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP)

Bills named: H.R. 4712 (116th)

Alcohol and Drug Abuse ALC

HR 4712, S3271 Fairness in Orphan Drug Exclusivity Act: General lobbying pertaining to opioid crisis; controlled substances and specialty pharmacies

Lobbyist	Covered position, as disclosed
EDWARD BUCKLEY	—

Contacted: Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4712 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.